By Conjoint Professor Dedee Frances Murrell

Journal articles

Daniel BS; Skowronski G; Myburgh J; Hersch M; Murrell DF, 2012, 'Concurrent Management of Toxic Epidermal Necrolysis with Thermal Water Spray and Non-Stick Dressings', Acta Dermatovenerologica Croatica, 20, pp. 210 - 212

Kopecki Z; Ruzehaji N; Turner C; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ, 2012, 'APPLICATION OF FLII NEUTRALIZING ANTIBODIES REDUCES THE SEVERITY OF SKIN BLISTERING IN A COLVII MODEL OF EPIDERMOLYSIS BULLOSA ACQUISITA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zane LT; Gebauer KA; Spelman L; Murrell DF; Varigos GA; Heerinckx FA; Jermano JA; Zib B; Gogoleva T, 2012, 'BORON-BASED AN2728 AND AN2898 OINTMENTS DEMONSTRATE SAFETY AND EFFICACY IN A PHASE 2A BILATERAL STUDY OF MILD-TO-MODERATE ATOPIC DERMATITIS', WOUND REPAIR AND REGENERATION, 20, pp. A69 - A69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Venugopal S; Yan W; Frew JW; Cohn HI; Tran K; Sturm M; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Khan MT; Murrell DF, 2012, 'PODIATRY ASSESSMENT FOR EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 20, pp. A72 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Oh L; Daniel B; Murrell DF, 2012, 'REVIEW OF SIDE EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED FOR AUTOIMMUNE BLISTERING DISEASES', WOUND REPAIR AND REGENERATION, 20, pp. A76 - A76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim M; Li M; Intong LRA; Tran K; Melbourne W; Marucci D; Inder S; de Souza P; Mallesara G; Murrell DF, 2012, 'USE OF CETUXIMAB AS AN ADJUVANT AGENT TO RADIOTHERAPY AND SURGERY IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA WITH SQUAMOUS CELL CARCINOMA', WOUND REPAIR AND REGENERATION, 20, pp. A60 - A60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sebaratnam DF; Hanna A; Chee S; Frew JW; Tan JCK; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF, 2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Murrell DF, 2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008

Venugopal SS; Murrell DF, 2012, 'Diagnosis and Clinical Features of Pemphigus Vulgaris', Immunology and Allergy Clinics of North America, 32, pp. 233 - 243, http://dx.doi.org/10.1016/j.iac.2012.04.003

Daniel BS; Murrell DF; Joly P, 2012, 'Rituximab and its Use in Autoimmune Bullous Disorders', Immunology and Allergy Clinics of North America, 32, pp. 331 - 337, http://dx.doi.org/10.1016/j.iac.2012.04.013

Chee SN; Murrell DF, 2012, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Immunology and Allergy Clinics of North America, 32, pp. 323 - 330, http://dx.doi.org/10.1016/j.iac.2012.04.012

Murrell DF; Daniel BS; Joly P; Borradori L; Amagai M; Hashimoto T; Caux F; Marinovic B; Sinha AA; Hertl M; Bernard P; Sirois D; Cianchini G; Fairley JA; Jonkman M; Pandya A; Rubenstein D; Zillikens D; Payne A; Woodley D; Zambruno G; et A, 2012, 'Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.', Journal of the American Academy of Dermatology, 66, pp. 479 - 485, http://dx.doi.org/10.1016/j.jaad.2011.06.032

Chow HT; Tran K; Millar EKA; Lynch J; Murrell DF, 2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938

Ng YZ; Pourreyron C; Salas-Alanis J; Dayal JHS; Cepeda-valdes R; Yan W; Wright SW; Chen M; Fine J; Hogg FJ; Mcgrath J; Murrell DF; Leigh IM; Lane EB; South AP, 2012, 'Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma complicating patients with recessive dystrophic epidermolysis bullosa.', Cancer Research, 72, pp. 3522 - 3534, http://dx.doi.org/10.1158/0008-5472.CAN-11-2996

Intong LR; Murrell DF, 2012, 'Inherited epidermolysis bullosa: New diagnostic criteria and classification', Clinics in Dermatology, 30, pp. 70 - 77, http://dx.doi.org/10.1016/j.clindermatol.2011.03.012

Sarig O; Bercovici S; Zoller L; Goldberg I; Indelman M; Nahum S; Sagiv N; Martinez de morentin H; Katz O; Baum S; Barzilai A; Trau H; Murrell DF; et A, 2012, 'Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris.', Journal of Investigative Dermatology, 132, pp. 1798 - 1805, http://dx.doi.org/10.1038/jid.2012.46

Sebaratnam DF; Frew JW; Davatchi F; Murrell DF, 2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008

Daniel BS; Hertl M; Werth VP; Eming R; Murrell DF, 2012, 'Severity score indexes for blistering diseases', Clinics in Dermatology, 30, pp. 108 - 113, http://dx.doi.org/10.1016/j.clindermatol.2011.03.017

Schmitt J; Spuls P; Boers M; et A; Murrell DF; Al 15 E, 2012, 'Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.', Allergy, 67, pp. 1111 - 1117, http://dx.doi.org/10.1111/j.1398-9995.2012.02874.x

Garcia-Mendoza C; Murrell D, 2011, 'Adolescent acne', Australian Doctor, pp. 39 - 40

Garcia-Mendoza C; Murrell D, 2011, 'Treating psoriasis', Australian Doctor, pp. 37 - 38

Intong LRA; Murrell DF, 2011, 'Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis', , 1, pp. 1 - 8, http://dx.doi.org/10.1002/9781444345384.ch78

Murrell D; Daniel B, 2011, 'Atopic dermatitis', Australian Doctor, pp. 35 - 36

Martin L; Werth VP; Villaneuva E; Murrell DF, 2011, 'A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus', Journal of the American Academy of Dermatology, 64, pp. 903 - 908, http://dx.doi.org/10.1016/j.jaad.2010.04.039

Murrell DF; Ryan T; Bergfeld W, 2011, 'Advancement of women in dermatology', International Journal of Dermatology, 50, pp. 593 - 600, http://dx.doi.org/10.1111/j.1365-4632.2011.05075.x

Murrell DF; Sebaratnam DF, 2011, 'Bullous Systemic Lupus Erythematosus', Dermatologic Clinics, 29, pp. 649 - 653, http://dx.doi.org/10.1016/j.det.2011.06.002

Frew J; Murrell DF, 2011, 'Corticosteroid Use in Autoimmune Blistering Diseases', Dermatologic Clinics, 29, pp. 535 - 544, http://dx.doi.org/10.1016/j.det.2011.06.004

Frew J; Murrell DF, 2011, 'Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome)', Dermatologic Clinics, 29, pp. 607 - 612, http://dx.doi.org/10.1016/j.det.2011.06.016

Yiu EM; Klausegger A; Waddell L; Grasern N; Lloyd L; Tran KT; North K; Bauer J; Mckelvie PA; Chow CW; Ryan M; Murrell DF, 2011, 'Epidermolysis bullosa with late-onset muscular dystrophy and plectin deficiency', Muscle and Nerve, 44, pp. 135 - 141, http://dx.doi.org/10.1002/mus.22076

Daniel BS; Borradori L; Hall RP; Murrell DF, 2011, 'Evidence-Based Management of Bullous Pemphigoid', Dermatologic Clinics, 29, pp. 613 - 620, http://dx.doi.org/10.1016/j.det.2011.06.003

Lehman ; Murrell DF; Camilleri ; Kalaaji , 2011, 'Infection and Infection Prevention in Patients Treated with Immunosuppressive Medications for Autoimmune Bullous Disorders', Dermatologic Clinics, 29, pp. 591 - 598, http://dx.doi.org/10.1016/j.det.2011.06.021

Intong L; Murrell DF, 2011, 'Management of Epidermolysis Bullosa Acquisita', Dermatologic Clinics, 29, pp. 643 - 647, http://dx.doi.org/10.1016/j.det.2011.06.020

Kopecki Z; Arkell R; Strudwick XL; Hirose M; Ludwig R; Kern JS; Bruckner-Tuderman L; Zillikens D; Murrell DF; Cowin A, 2011, 'Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita', Journal of Pathology, 225, pp. 401 - 413, http://dx.doi.org/10.1002/path.2973

Intong L; Murrell DF, 2011, 'Pemphigoid Gestationis: Current Management', Dermatologic Clinics, 29, pp. 621 - 628, http://dx.doi.org/10.1016/j.det.2011.06.013

Daniel BS; Murrell DF; Joly P, 2011, 'Rituximab and its Use in Autoimmune Bullous Disorders', Dermatologic Clinics, 29, pp. 571 - 575, http://dx.doi.org/10.1016/j.det.2011.06.023

Daniel BS; Dermawan A; Murrell DF, 2011, 'The Autoimmune Blistering Diseases in Australia: Status and Services', Dermatologic Clinics, 29, pp. 687 - 690, http://dx.doi.org/10.1016/j.det.2011.07.002

Murrell DF; Werth VP; Segall JD; Zrnchik W; Stuart M; Sirois D, 2011, 'The International Pemphigus and Pemphigoid Foundation', Dermatologic Clinics, 29, pp. 655 - 657, http://dx.doi.org/10.1016/j.det.2011.06.019

Chee S; Murrell DF, 2011, 'The Use of Intravenous Immunoglobulin in Autoimmune Bullous Diseases', Dermatologic Clinics, 29, pp. 565 - 570, http://dx.doi.org/10.1016/j.det.2011.06.010

Venugopal SS; Murrell DF, 2010, 'Diagnosis and prevention of bullous diseases', , pp. 115 - 135, http://dx.doi.org/10.1007/978-1-84996-021-2_12

Murrell DF; Klausegger A; Wadell LB; Grasern N; Lloyd L; Tran K; Melbourne W; Yiu E; Bauer JW; North KN; Ryan M, 2010, 'Adult onset muscular dystrophy associated with epidermolysis bullosa simplex and plectin deficiency - the first Australian case and genotype-phenotype correlations', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A8 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daniel BS; Venugopal SS; Murrell DF, 2010, 'Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papilloma virus (HPV) vaccine', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A9 - A9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cohn H; Tran K; Chow CW; Palmer E; Turner A; Murrell DF, 2010, 'Dystrophic epidermolysis bullosa compound heterozygote presents with immunofluorescence findings evocative of transient bullous dermolysis of the newborn', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 51, pp. A8 - A8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Venugopal SS; Intong LRA; Cohn HI; Mather-Hillon J; Murrell DF, 2010, 'Responsiveness of nonHerlitz Junctional Epidermolysis Bullosa to topical gentian violet', International Journal of Dermatology, 49, pp. 1282 - 1285, http://dx.doi.org/10.1111/j.1365-4632.2010.04557.x

Venugopal SS; Yan H; Frew JW; Tran K; Melbourne W; Nelson J; Sturm M; Fogarty F; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2010, 'TRIAL OF FIBROBLAST CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 18, pp. A74 - A74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF, 2010, 'Epidemiology of epidermolysis bullosa in the antipodes: The Australasian epidermolysis bullosa registry with a focus on Herlitz junctional epidermolysis bullosa', Archives of Dermatology, 146, pp. 635 - 640, http://dx.doi.org/10.1001/archdermatol.2010.109

Van Geel M; Gattas M; Kesler Y; Tong P; Yan H; Tran K; Steijlen PM; Murrell DF; Van Steensel MAM, 2010, 'Phenotypic variability associated with WNT10A nonsense mutations', British Journal of Dermatology, 162, pp. 1403 - 1406, http://dx.doi.org/10.1111/j.1365-2133.2010.09703.x

Venugopal SS; Murrell DF, 2010, 'Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man', Archives of Dermatology, 146, pp. 475 - 477, http://dx.doi.org/10.1001/archdermatol.2010.71

Murrell DF, 2010, 'Epidermolysis bullosa in Australia and New Zealand', Dermatologic Clinics, 28, pp. 433 - 438, http://dx.doi.org/10.1016/j.det.2010.02.009

Yan WF; Murrell DF, 2010, 'Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa', Dermatologic Clinics, 28, pp. 367 - 370, http://dx.doi.org/10.1016/j.det.2010.01.015

Back to profile page